BioWorld

Sep. 19, 2003

View Archived Issues

Genta Receives Ganite Approval In Cancer-Related Hypercalcemia

Genta Inc. received its first drug approval Thursday when the FDA cleared Ganite for the treatment of cancer-related hypercalcemia that is resistant to hydration. (BioWorld Today) Read More

Memory Signs Roche To $150M Expansion Of CNS Collaboration

Read More

454 Life Sciences Secures $20M To Begin Commercial Operations

Read More

Conforma Placement Raises $30M For Cancer Therapies

Read More

Neurochem Increases IPO Share Amount, Expects To Raise $54M

Read More

Other News To Note

Read More